Harasha Pharma Private Limited - Due diligence report

A 360° intelligence report on Harasha Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

1997-01-02 New Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
HP Harasha Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Harasha Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Harasha Pharma Private Limited is assessed as Low Risk with a Trust Score of 78/100. Harasha Pharma Private Limited is an active private limited indian non-government company incorporated in 1997, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 13 Aug 2026 from the latest processed filings. Harasha Pharma Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (4.62 cr) · 5 satisfied (3.56 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank4 48.0 cr
Yes Bank Limited1 48.0 cr
Others1 48.0 cr
Syndicate Bank1 48.0 cr
Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MONIKA SINGLA 01234567 Director 01/04/2018 6 yrs Approved
Riman Gupta 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
8 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Operating for 29+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment56/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 4.62 cr already registered.
  • Compliance record supports lending.
Investor view70/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
23 Aug 2025
Director ceased
Tanney Manav Singla
13 Aug 2025
Director appointed
Riman Gupta (Director)
28 Feb 2025
Director ceased
MANAV HARSH SINGLA
30 Sep 2024
Last AGM held
Annual general meeting
25 Sep 2024
Charge satisfied
Yes Bank Limited
21 Sep 2024
Charge created
Others - 1.32 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
12 Jan 2023
Charge satisfied
Canara Bank
16 Dec 2022
Charge satisfied
Canara Bank
14 Sep 2022
Securities allotted
500000 Equity Shares - 50.00 Lakh raised
25 Mar 2022
Securities allotted
520000 Equity Shares - 52.00 Lakh raised
09 Nov 2021
Charge created
Canara Bank - 8.00 Lakh
19 Jun 2021
Charge created
Yes Bank Limited - 3.00 cr
02 Jun 2021
Charge created
Canara Bank - 21.90 Lakh
11 Feb 2021
Securities allotted
106594 Equity Shares - 10.66 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Kesho Ram Agricare Private Limited U24219UR2005PTC033449 Dehradun, Uttarakhand, India
Maypri Healthcare Private Limited U85191UP2014PTC064699 Noida, Uttar Pradesh, India
Vrnda Pharma Private Limited U51909MH2016PTC284291 Mumbai, Maharashtra, India
Shreenathji Heavy Engineers Private Limited U51900MH2008PTC187766 Mumbai, Maharashtra, India
Crm Enterprise Business Private Limited U51909WB2020PTC240310 Kolkata, West Bengal, India
Rajlaxmi Automotive Private Limited U50400OR2021PTC036722 Bolangir, Orissa, India
Ra Chemicals Limited U24110GJ2021PLC120752 Ahmedabad, Gujarat, India
Ideal Tridon Clamp (Mumbai) Company Private Limited U31501MH2014PTC252325 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Harasha Pharma Private Limited before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Harasha Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Harasha Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Harasha Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Harasha Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Harasha Pharma Private Limited an active company?

Harasha Pharma Private Limited has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Harasha Pharma Private Limited financially healthy?

Harasha Pharma Private Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Harasha Pharma Private Limited?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Harasha Pharma Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Harasha Pharma Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.

Is Harasha Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Harasha Pharma Private Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.